Printer Friendly

Edwards Lifesciences Acquires Harpoon Medical for $250M.

Edwards Lifesciences Corporation, developer of patient-focused innovations for structural heart disease and critical care monitoring, acquired Harpoon Medical Inc., a privately held medical technology company pioneering beating-heart repair for degenerative mitral regurgitation. Edwards announced a structured upfront investment in Harpoon in 2015, with an exclusive option to acquire the company.

Edwards paid $100 million in cash for Harpoon at closing on Dec. 1. In addition, there is the potential for up to $150 million in pre-specified milestone-driven payments over the next 10 years.

"We believe the addition of Harpoon Medical's technology and team will enable even more opportunities to help patients with degenerative mitral regurgitation," said Bernard Zovighian, Edwards' corporate vice president, surgical heart valve therapy. "The unique beating-heart repair procedure for mitral valve patients complements Edwards' portfolio of treatments for structural heart disease, and reinforces our commitment to innovation in cardiac surgery."

The HARPOON system is designed to facilitate echo-guided repair of mitral valve regurgitation by stabilizing the prolapsed mitral valve leaflet to restore proper coaptation and valve function. The HARPOON device is currently investigational and not available for commercial use. It is expected to receive CE mark approval soon.

"There are a significant number of patients currently undergoing mitral valve surgery that we believe can benefit from Harpoon's therapy during a minimally invasive, beating-heart procedure," said device inventor James S. Gammie, M.D., chairman of the company's scientific advisory board and professor and chief of cardiac surgery at the University of Maryland School of Medicine. "This therapy offers the potential for earlier treatment of degenerative mitral valve disease with faster recovery and less morbidity, while also providing the opportunity for more consistent procedures and outcomes for patients."

COPYRIGHT 2018 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:TOP OF THE NEWS
Publication:Medical Product Outsourcing
Date:Jan 1, 2018
Words:279
Previous Article:Siemens Healthineers Acquires Fast Track Diagnostics.
Next Article:MedTech M&A and Manufacturing Predictions for 2018.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters